Meet Our Featured Speakers

benefits

European Peptide Drug Summit 2026 brings together industry leaders to share cutting-edge market intelligence and present emerging developments in peptide therapies.

Benefits of attending include:

Two days of in-depth presentations showcasing the latest market intelligence, addressing the pharmaceutical industry's priorities through shared results and real-world experiences.
Exclusive networking opportunities to connect with professionals who share similar challenges and experiences in this rapidly evolving sector.
Updates on regional projects and research led by leading peptide synthesis experts and manufacturers, sharing their experiences, findings, and new proposals.
Technical presentations from peptide drug developers highlighting the latest findings from recent tests and trials, technological advances, and emerging technical insights.
New case studies featuring specific examples from leading industry experts involved in peptide medicine development initiatives.
A unique opportunity to connect with a wide range of manufacturers and explore new market opportunities by sharing insights into this evolving industry.

key takeaways

Understand the current market dynamics shaping peptides as biopharmaceutical drugs
Learn how to develop effective strategies for peptide drug formulations and delivery systems
Hear the latest trends and forecasts shaping peptide synthesis and manufacturing processes
Discuss innovations and technological developments across a variety of peptide drug types
Access insights from a wide range of experts and allied industries, drawing on regional experiences

who should attend?

This event is aimed at leading pharmaceutical companies, drug developers, and healthcare industry leaders seeking to expand their understanding of peptide drugs and the future of clinical care.

Core attendees include CEOs, COOs, CFOs, Presidents, Vice Presidents, Directors, Heads of, Superintendents, and Managers involved in:

Drug Development Experts Drug Manufacturing Business Development Drug Delivery Technologists Drug Formulation Experts Clinical Trials and Approvals Drug Discovery Clinical Trials Manufacturing Research & Innovation Biotherapeutics & Biologics Clinical Diagnostics Research and Development Biotechnology Researchers Companion Diagnostics Strategy, Projects, & Public Affair Nanotechnologies Theragnostic Sales and Marketing Initiatives Nano & Micro Robotics System Biology and Research Legal and Regulatory Modalities Research Precision Medicine Equipment Certification Services Molecular Medicine Laboratory Equipment News Reporting and Journalism

they've attended our events

Barry Rosen

Sanofi

"The conference was excellent, offering very useful insights. The agenda was highly relevant."

Ying Wang

Johnson & Johnson

"It was a highly engaging event with numerous opportunities to connect with others in the field."

Mike Zimmer

Novartis

"The conference offered valuable learning and networking opportunities."

Muhammad Umar Khan

GlaxoSmithKline

"I loved the show! It was very enlightening and attended by a fantastic group of people."

Anne Renton

Merck

"Exceptional speakers showcased innovations and results from across the industry."

Carolyn Dulney

Roche

"There were great discussions and great networking opportunities."

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.